Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: a systematic review
Newborns are particularly susceptible to off-label and unlicensed (OLUL) drug treatments, especially in the intensive care setting, inferring from dosing regimens and indications supported in older populations and built on non-neonatal pathophysiology. This use leads to unpredictable drug effectiven...
Saved in:
Main Authors: | Fábio Reis (Author), Rita Pissarra (Author), Henrique Soares (Author), Paulo Soares (Author), Hercília Guimarães (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
by: Leila Kouti, et al.
Published: (2019) -
Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit
by: Meles Tekie Gidey, et al.
Published: (2020) -
Off-label and unlicensed drugs in neonatology
by: Segundo Rite-Gracia, et al.
Published: (2021) -
Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital
by: Adriana Cristina de Souza Gonçalves, et al.
Published: (2018) -
Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
by: Laura Goedel dos Santos, et al.
Published: (2023)